Literature DB >> 24378999

Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.

Carolina De Ciuceis1, Massimo Salvetti, Claudia Rossini, Maria Lorenza Muiesan, Anna Paini, Sarah Duse, Elisa La Boria, Francesco Semeraro, Anna Cancarini, Claudia Agabiti Rosei, Annamaria Sarkar, Giuseppina Ruggeri, Luigi Caimi, Doris Ricotta, Damiano Rizzoni, Enrico Agabiti Rosei.   

Abstract

BACKGROUND: It has been previously demonstrated that dihydropyridine calcium channel blockers may possess antioxidant properties and might improve vascular structure. Combination treatment with an angiotensin-converting enzyme inhibitor may have additional advantages, compared with a thiazide diuretic, in this regard. The aim of the present study was, therefore, to investigate the effects of a short-term treatment with lercanidipine, and to compare two combination treatments: lercanidipine + enalapril vs. lercanidipine + hydrochlorothiazide on structural alterations in retinal arterioles, on skin capillary density and on large artery distensibility. PATIENTS AND METHODS: Twenty essential hypertensive patients were included in the study and treated for 4 weeks with lercanidipine 20 mg per day orally. Then they were treated for 6 months with lercanidipine + enalapril (n=10) or lercanidipine + hydrochlorothiazide (n=10) combinations. Investigations were performed in basal condition, after appropriate washout of previous treatments, after 4 weeks of lercanidipine monotherapy treatment, and at the end of the combination treatment. Non-invasive measurements of wall-to-lumen ratio (W/L) and other morphological parameters of retinal arterioles using scanning laser Doppler flowmetry were performed (Heidelberg Retina Flowmeter, Heidelberg Engineering). Capillary density was evaluated by capillaroscopy, whereas pulse wave velocity and central blood pressure were assessed by the Sphygmo-Cor device (AtCor Medical West Ryde, Australia).
RESULTS: A significant improvement of W/L and of other indices of retinal artery structure was observed after treatment with lercanidipine alone, with a further improvement after treatment with lercanidipine + enalapril, whereas after treatment with lercanidipine + hydrochlorothiazide the improvement was no longer observed. A similar behaviour was observed for central SBP and DBP. Capillary density was increased only after treatment with lercanidipine + enalapril.
CONCLUSION: Lercanidipine both in monotherapy and in combination with enalapril, was able to improve microvascular structure and to decrease central blood pressure, being thus a useful approach for both reducing blood pressure and improving vascular alterations in hypertension.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24378999     DOI: 10.1097/HJH.0000000000000067

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  8 in total

1.  Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.

Authors:  Carolina De Ciuceis; Massimo Salvetti; Anna Paini; Claudia Rossini; Maria Lorenza Muiesan; Sarah Duse; Stefano Caletti; Maria Antonietta Coschignano; Francesco Semeraro; Valentina Trapletti; Fabio Bertacchini; Valeria Brami; Alina Petelca; Enrico Agabiti Rosei; Damiano Rizzoni; Claudia Agabiti Rosei
Journal:  Intern Emerg Med       Date:  2017-06-24       Impact factor: 3.397

2.  Relationships between retinal arteriole anatomy and aortic geometry and function and peripheral resistance in hypertensives.

Authors:  David Rosenbaum; Nadjia Kachenoura; Edouard Koch; Michel Paques; Philippe Cluzel; Alban Redheuil; Xavier Girerd
Journal:  Hypertens Res       Date:  2016-03-24       Impact factor: 3.872

Review 3.  Salt-induced effects on microvascular function: A critical factor in hypertension mediated organ damage.

Authors:  Maria E Marketou; Spyros Maragkoudakis; Ioannis Anastasiou; Helen Nakou; Marina Plataki; Panos E Vardas; Fragiskos I Parthenakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-04-19       Impact factor: 3.738

4.  Improvement in Retinal Capillary Rarefaction After Valsartan Treatment in Hypertensive Patients.

Authors:  Agnes Jumar; Joanna M Harazny; Christian Ott; Iris Kistner; Stefanie Friedrich; Roland E Schmieder
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-16       Impact factor: 3.738

Review 5.  Lercanidipine/enalapril combination in the management of obesity-related hypertension.

Authors:  Guido Grassi
Journal:  Integr Blood Press Control       Date:  2016-04-26

Review 6.  Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.

Authors:  Christina Antza; Stella Stabouli; Vasilios Kotsis
Journal:  Vasc Health Risk Manag       Date:  2016-11-15

7.  Retinal capillary rarefaction in patients with untreated mild-moderate hypertension.

Authors:  Agnes J Bosch; Joanna M Harazny; Iris Kistner; Stefanie Friedrich; Joanna Wojtkiewicz; Roland E Schmieder
Journal:  BMC Cardiovasc Disord       Date:  2017-12-21       Impact factor: 2.298

Review 8.  Lercanidipine in the Management of Hypertension: An Update.

Authors:  Guido Grassi; Nicolàs R Robles; Gino Seravalle; Francesco Fici
Journal:  J Pharmacol Pharmacother       Date:  2017 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.